Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Physiol.

Sec. Vascular Physiology

Volume 16 - 2025 | doi: 10.3389/fphys.2025.1655946

Arterial Compliance is Improved via Enteral Serine Protease Inhibition in Experimental Trauma/Hemorrhagic Shock

Provisionally accepted
  • 1Department of Bioengineering, University of California, San Diego, La Jolla, United States
  • 2Department of Anesthesiology & Critical Care, University of California, San Diego, La Jolla, United States
  • 3Instituto do Coração, Universidade de Sao Paulo, São Paulo, Brazil
  • 4Laboratory of Molecular and Experimental Pathology, Universidade Federal de Sao Paulo, São Paulo, Brazil
  • 5VA San Diego Healthcare System, San Diego, United States

The final, formatted version of the article will be published soon.

Background: Systemic hypotension remains a challenge in trauma/hemorrhagic shock (T/HS). Despite intensive vasopressor and fluid therapy, mean arterial blood pressure (MAP) may become refractory to treatment. Arterial compliance (AC) is a critical determinant of arterial hemodynamics but is often overlooked in acute shock states. Considering previous findings on the benefits of enteral protease inhibition in preserving vascular resistance after T/HS, this study investigated both the role of AC and the effects of enteral protease inhibition on AC in T/HS. Methods: Wistar rats underwent experimental T/HS by laparotomy and exsanguination to induce a MAP of ~40mmHg for 90 minutes. Animals were randomized into three groups corresponding to the intervention: shed whole blood (WB), Lactated Ringer's (LR), and LR with enteral gabexate mesilate treatment (LR+GM). Resuscitation (120-minute period) was initiated by fluid reperfusion with a goal MAP of 65mmHg. AC was measured via pulse wave velocity (PWV), passive pressure myography, and atomic force microscopy (AFM), with healthy donor arteries for comparison.Results: PWV increased by ~15% in all groups after shock. After resuscitation, LR-only animals maintained high PWVs, but significantly lower diastolic pressures (27mmHg) compared to GM-treated (37mmHg; p<0.05) and thse reperfused with WB (52mmHg; p<0.01). T/HS arteries, particularly the untreated LR arteries, exhibited leftward shifts in circumferential tension-strain curves. LR arteries exhibited higher tangent moduli (5 N/m; p < 0.01) at low physiological stresses, which was corroborated by reduced opening angles, increased mechanical stiffness, alterations in the extracellular matrix, and increased MMP/elastase-like activity. LR+GM and WB arteries displayed elastic moduli and vascular structures more similar to those of healthy arteries.Conclusions: Experimental T/HS results in impaired AC, which is partially attenuated by enteral GM administration. Vascular biomechanical impairment may underlie the unrestored MAP in fulminant shock. By targeting modulators of AC, with enteral serine protease inhibition as an adjunct intervention, hemodynamic stability and patient outcomes may be improved in T/HS.

Keywords: Trauma, hemorrhagic shock, arterial compliance, Diastolic pressure, protease inhibition, Circulatory shock, Resuscitation

Received: 29 Jun 2025; Accepted: 28 Jul 2025.

Copyright: © 2025 Li, dos Santos, Muller, Moreira, Borges, Irigoyen, Schmid-Schönbein and Kistler. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Joyce Beverly Li, Department of Bioengineering, University of California, San Diego, La Jolla, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.